Chitosan-based electrospun nanofibers for diabetic foot ulcer management; recent advances

Carbohydr Polym. 2023 Aug 1:313:120512. doi: 10.1016/j.carbpol.2022.120512. Epub 2023 Jan 2.

Abstract

Diabetic foot ulcer (DFU) healing has long been a major medical challenge. The type of dressing is an essential factor in wound healing, prevention of local infection, and scar formation. Today, smart wound dressings or wound healing patches can precisely control drug delivery to the target tissue and prevent this significant complication. Nanofiber (NF) wound dressings are effective in reducing wound scarring and helping to speed up the healing process for DFU. The electrospun NFs have a suitable surface topography, density, and three-dimensional structure, which can be considered an efficient method to produce a substrate for tissue engineering and wound healing. Chitosan (CS) is one of the most well-known biopolymers in wound healing tissue engineering and drug delivery systems. The unique properties of CS make it suitable for biomedical applications. Based on new studies in the field of hemostatic and antimicrobial effects of CS in controlling bleeding and wound healing and application of NF wound dressings, the purpose of this study is a review relevant works on CS-based NFs to improve the DFU.

Keywords: Chitosan; Diabetic foot ulcers; Electrospinning; Nanofibers; Wound healing.

Publication types

  • Review

MeSH terms

  • Bandages
  • Chitosan* / pharmacology
  • Chitosan* / therapeutic use
  • Cicatrix
  • Diabetes Mellitus*
  • Diabetic Foot* / drug therapy
  • Humans
  • Nanofibers* / chemistry
  • Nanofibers* / therapeutic use
  • Wound Healing

Substances

  • Chitosan